Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway

Despite the proven clinical antineoplastic activity of histone deacetylase inhibitors (HDACI), their effect has been reported to be lower than expected in B-cell lymphomas. Traditionally considered as “epigenetic drugs”, HDACI modify the acetylation status of an extensive proteome, acting as general...

Descripción completa

Detalles Bibliográficos
Autores principales: Pera, Benet, Krumsiek, Jan, Assouline, Sarit E., Marullo, Rossella, Patel, Jayeshkumar, Phillip, Jude M., Román, Lidia, Mann, Koren K., Cerchietti, Leandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835559/
https://www.ncbi.nlm.nih.gov/pubmed/29396295
http://dx.doi.org/10.1016/j.ebiom.2018.01.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835559/
https://www.ncbi.nlm.nih.gov/pubmed/29396295
http://dx.doi.org/10.1016/j.ebiom.2018.01.014

Ejemplares similares